Welcome to our dedicated page for First Choice Hea SEC filings (Ticker: FCHS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on First Choice Hea's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into First Choice Hea's regulatory disclosures and financial reporting.
First Choice Healthcare Solutions, Inc. (FCHS) filed an amended S-1 describing recent operations, balance sheet composition, financing instruments and acquisitions. The company reported revenue of $2,815,401 for 2025 compared with $2,346,997 in 2024, while Pointe Med/LiveWell contributed $4,784,910 in revenue in the referenced period. Net losses were approximately $2.0 million for the six months ended June 30, 2025 and $3.8 million and $8.2 million for the years ended December 31, 2024 and 2023, respectively. Accumulated deficit was stated at approximately $69.8 million at June 30, 2025.
The filing discloses material liabilities and financing arrangements including substantial convertible notes (e.g., 35% OID notes of $5.6 million and total convertible notes aggregated to $14,000,962), lease liabilities in the multi‑million dollar range (total lease liabilities reported around $3.46 million), and other non‑convertible notes. The company completed acquisitions (Pointe Med/LiveWell; The Good Clinic) with share consideration and records intangible assets of $17,533,783 tied to acquisition accounting. Management discloses a going concern risk tied to recurring losses and says it must raise at least $10.0 million to complete the proposed offering and uplist to the NYSE.
